Skip to main content
ALLIANCE PHARMA PLC logo

ALLIANCE PHARMA PLC — Investor Relations & Filings

Ticker · APH ISIN · GB0031030819 LEI · 213800RYIWZA4Q5WPZ13 IL Wholesale and retail trade
Open in API
Filings indexed 492 across all filing types
Latest filing 2022-04-06 Major Shareholding Noti…
Country GB United Kingdom
Listing IL APH

About ALLIANCE PHARMA PLC

https://www.alliancepharmaceuticals.com/

Alliance Pharma PLC is an international specialty pharmaceutical company with a primary focus on consumer healthcare. The company's business model is centered on the acquisition, licensing, and marketing of a portfolio of consumer health products and prescription medicines. It operates globally, investing in its key brands to empower consumers to improve their health and wellbeing. A core part of its strategy is the ongoing development to become a high-performing consumer healthcare company.

Recent filings

Filing Released Lang Actions
Notification of Major Holdings
Major Shareholding Notification Classification · 99% confidence The document is identified by the header 'RNS Number : 4864H' and contains the standard boilerplate text indicating it is distributed by 'RNS, the news service of the London Stock Exchange'. The content itself is a 'TR-1: Standard form for notification of major holdings', detailing changes in voting rights held by FMR LLC, crossing a threshold (from 10.017% to 9.995%). This type of mandatory disclosure regarding significant share ownership changes falls under regulatory reporting. Since it is a specific regulatory filing notification that doesn't fit the definitions for 10-K, AR, ER, or IR, and it is not an announcement of a report (RPA), the most appropriate classification is the general regulatory filing category, RNS.
2022-04-06 English
Annual Report and Notice of AGM
AGM Information Classification · 98% confidence The document is a short announcement (3665 characters) released via RNS (London Stock Exchange news service). The core content explicitly states that two documents, the 'Annual Report & Accounts for the year ended 31 December 2021' and the 'Notice of the 2022 Annual General Meeting ("AGM")', are now available on the Group's website. According to Rule 2 ('MENU VS MEAL' Rule), when a document announces the publication of a report rather than containing the full report itself, it should be classified as a Report Publication Announcement (RPA). The document is clearly announcing the availability of the Annual Report (10-K) and AGM materials (AGM-R), making RPA the most appropriate classification for this announcement.
2022-04-05 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal notification released via RNS (Regulatory News Service) on April 4, 2022. The content explicitly states it is a notification in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1, providing the 'Total Voting Rights' as of March 31, 2022. This type of mandatory disclosure regarding the total number of shares and voting rights is a specific regulatory filing. While it is a regulatory announcement, it doesn't fit the specific definitions for DVA (Voting Results), DIRS (Director's Dealing), or SHA (Share Issue/Capital Change). Since it is a mandatory, non-standard regulatory update that doesn't fit the other specific categories, the most appropriate classification is the general regulatory filing category, RNS.
2022-04-04 English
Acquisition to access US scar treatment market
Regulatory Filings Classification · 98% confidence The document is a formal announcement released via RNS (RNS Number : 0680G) on March 25, 2022, detailing the completion of an acquisition by Alliance Pharma PLC. It discusses strategic rationale, financial impact, and concludes with a statement that the announcement contains inside information for the purposes of MAR regulations. This structure—a brief announcement of a significant corporate event (an acquisition) disseminated through a regulatory news service—is characteristic of a general regulatory filing or announcement that doesn't fit the specific financial report categories (like 10-K, IR, ER). Since it is a formal, non-standardized announcement disseminated via RNS, the most appropriate classification is Regulatory Filings (RNS), as it serves as the general regulatory announcement category.
2022-03-25 English
Results for the year ended 31 December 2021
Earnings Release Classification · 99% confidence The document is titled 'Unaudited Preliminary Results for the year ended 31 December 2021' and contains extensive financial tables summarizing revenue, profit, EPS, and cash flow for the year 2021 compared to 2020. It includes detailed operating and financial highlights, management commentary on performance, and an outlook for 2022. This content structure is characteristic of a comprehensive annual financial report. Although it is released via RNS (RNS Number : 5241F), the content itself is the full set of preliminary annual results, which aligns best with the 'Annual Report' category (10-K) or, given the 'Preliminary' nature and the context of UK reporting (often preceding the full audited 10-K equivalent), the 'Interim/Quarterly Report' (IR) if it were shorter, or potentially an Earnings Release (ER) if it were just highlights. However, the depth of detail provided (full P&L summary, segment analysis, management discussion) strongly suggests a comprehensive report. Since the definition for 10-K is 'Official yearly report covering company activity and full financial performance,' and this document covers the full year ended 31 December 2021, 10-K is the most appropriate classification for a full-year financial disclosure, even if it is preliminary/unaudited. If a specific 'Preliminary Annual Report' code existed, it would be used, but 10-K is the closest fit for a full-year financial disclosure. FY 2021
2022-03-22 English
Statement regarding potential acquisition
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content discusses 'discussions with a third party regarding a potential acquisition' and confirms the announcement is made under MAR regulations. This structure—a brief, immediate announcement of corporate activity (potential M&A) distributed via the RNS system—fits the definition of a general regulatory announcement that doesn't map to a specific financial report (like 10-K or IR) or a specific corporate action announcement (like DIV or SHA). Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as the general regulatory announcement category.
2022-03-21 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.